Colorectal Cancer Screening and Diagnostic Market to Grow with a CAGR of 5.34% through 2030
Technological
advancements in non-invasive diagnostic tools and the growing geriatric
population prone to colorectal cancer, is expected to
drive the Global Colorectal Cancer Screening and Diagnostic Market growth in
the forecast period, 2026-2030
According to
TechSci Research report, “Colorectal Cancer Screening and Diagnostic Market
– Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Colorectal Cancer Screening and
Diagnostic Market stood at USD
15.08 Billion in 2024 and is expected to reach USD 20.63 Billion by
2030 with a CAGR of 5.34% during the forecast period. The Global Colorectal Cancer Screening
and Diagnostic Market is expanding due to changing lifestyle patterns,
including rising consumption of processed foods, red meat, and alcohol, coupled
with sedentary behavior all of which increase the risk of colorectal cancer.
Growing prevalence of obesity and metabolic disorders such as type 2 diabetes
has further elevated risk factors. As colorectal cancer is often asymptomatic
in early stages, the importance of early detection is gaining attention among
general practitioners and healthcare providers. Insurance providers and
national healthcare systems are also beginning to include screening tests in
preventive care packages, driving wider adoption. As the average age of the
global population continues to rise, the risk pool for colorectal cancer is
also expanding, pushing more patients into recommended screening brackets.
The
market is also benefitting from the expansion of diagnostic infrastructure and
private healthcare investment. Diagnostic laboratories and independent
diagnostic chains are increasing their footprint in both urban and semi-urban
areas, offering specialized services for cancer screening. Collaborations
between hospitals, research institutes, and diagnostic firms are enabling
development of novel biomarkers and real-time screening tools. Increasing
physician training and the incorporation of colorectal screening into standard
care pathways are boosting uptake. The use of telehealth for pre- and
post-screening consultations is facilitating patient follow-up and monitoring,
which is vital for diagnostic accuracy and continuity of care.
The
Global Colorectal Cancer Screening and Diagnostic Market presents significant
growth opportunities, particularly through integration with digital health
ecosystems. Electronic health records (EHRs) and digital diagnostic platforms
allow for streamlined screening reminders, test ordering, and follow-up care.
There's also strong potential in the development of wearable biosensors and
smart colonoscopes capable of real-time data collection and transmission, which
could improve diagnostic precision. Investment in precision medicine offers
another avenue, with companion diagnostics being developed to tailor screening
and treatment pathways to individual genetic risk profiles. Pharmaceutical and
diagnostics companies can benefit from investing in multiplex screening kits
that can detect multiple gastrointestinal diseases simultaneously. Emerging
markets with underdeveloped screening infrastructure represent untapped
potential for both low-cost screening kits and mobile diagnostic units.
Strategic partnerships with governments and NGOs can help scale these
innovations and reach wider populations.
Browse over XX market data Figures and spread through XX Pages and an
in-depth TOC on "Colorectal Cancer Screening and Diagnostic Market”
The Global Colorectal Cancer Screening and Diagnostic
Market is segmented into screening, diagnostics, end user, regional
distribution, and company.
Based on the End
User, Hospitals and Clinics emerged as the fastest growing segment in the Global
Colorectal Cancer Screening and Diagnostic Market during the forecast period. This growth is primarily driven by the
increasing availability of advanced diagnostic infrastructure and skilled
healthcare professionals in hospital and clinical settings. Hospitals and
clinics serve as the primary point of care for a majority of the population,
especially for procedures like colonoscopies, sigmoidoscopies, and biopsies
that require specialized equipment and expertise. The expansion of
multispecialty hospitals, particularly in emerging economies, has further
bolstered access to comprehensive colorectal cancer screening services under
one roof. Moreover, the growing incidence of colorectal cancer globally has
prompted governments and healthcare institutions to expand their screening
programs through hospitals and clinics. These facilities also benefit from
direct collaborations with diagnostic companies to integrate cutting-edge
technologies such as blood-based and DNA-based testing for early cancer
detection. Additionally, patients increasingly prefer hospitals and clinics for
routine cancer screening due to the perception of greater accuracy, reliability,
and post-screening support.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Colorectal Cancer Screening and Diagnostic Market during the forecast period. The adoption
of Westernized diets rich in processed foods and red meat has been linked to
higher colorectal cancer risks, particularly in countries experiencing rapid
urbanization. Alongside lifestyle-related risk factors, greater private sector
participation in cancer diagnostics and the expansion of insurance coverage are
enabling more individuals to seek preventive healthcare services. Diagnostic
companies are also targeting the Asia-Pacific region for strategic expansions,
given the untapped market potential and favorable regulatory frameworks in
several nations. Furthermore, advancements in minimally invasive and
non-invasive diagnostic technologies, including liquid biopsy and ctDNA
analysis, are being increasingly adopted in countries like South Korea and
Japan, which are known for their innovation in medical technology. These
trends, coupled with a rising middle-class population that prioritizes
preventive health, are expected to continue fueling robust market growth for
colorectal cancer screening and diagnostics in the Asia-Pacific region during
the forecast period.
Some
of the major companies operating in the Global
Colorectal Cancer Screening and Diagnostic Market are:
- Clinical
Genomics Technologies Pty Ltd.
- Danaher
Corporation
- DiaCarta,
Inc.
- Eiken
Chemical Co., Ltd.
- Epigenomics AG
- Freenome
Holdings, Inc.
- Guardant
Health, Inc.
- Lepu
Medical Technology (Beijing) Co., Ltd.
- Novigenix
SA
- FUJIFILM
Holdings Corporation
- Olympus
Corporation
- QuidelOrtho
Corporation
Download Free Sample Report
Customers can also request
10% free customization on this report
“The Global
Colorectal Cancer Screening and Diagnostic Market is expanding due to the
growing implementation of national and regional government screening programs
aimed at early cancer detection, particularly in middle-income countries. Many
governments are introducing population-based screening initiatives using fecal
occult blood tests (FOBT), fecal immunochemical tests (FIT), and colonoscopy to
reduce cancer mortality through early intervention. These programs are often
supported by public awareness campaigns and funding from health ministries or
international health organizations, significantly improving screening rates and
diagnosis at earlier, more treatable stages. This strategic public health focus
is fueling market growth across both urban and rural settings.,” said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Colorectal Cancer
Screening and Diagnostic Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Screening (Stool-Based Test,
Colonoscopy and Sigmoidoscopy, Others), By Diagnostics (Biomarker Test,
Colonoscopy), By End User (Hospitals and Clinics, Clinical Laboratories,
Others), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Colorectal Cancer Screening and
Diagnostic Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Colorectal Cancer
Screening and Diagnostic Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com